BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:In 2025\, cell and gene therapy reached a pivotal moment. Amid
  rising tariffs\, shifting regulations\, and capacity constraints\, the i
 ndustry gained clarity on what it takes to scale successfully. As a resul
 t\, the focus on scaling novel therapies safely and efficiently has never
  been stronger\, introducing a new era of operational excellence and expa
 nded patient access.\n\nAs we enter 2026\, AI\, digitalization\, and IoT 
 are transforming how cell and gene therapies are planned\, tracked\, and 
 delivered end-to-end. With smarter\, data-driven decision-making\, supply
  chain teams can better navigate tariff fluctuations\, manufacturing vari
 ability\, and regulatory complexity.\n\nDesigned by and for supply chain 
 leaders across biopharma\, including Roche\, Bristol Myers Squibb\, Johns
 on and Johnson\, Genentech\, ProKidney\, and Vyriad the 7th Supply Chain 
 and Logistics for Cell and Gene Therapy Summit delivers best-in-class per
 spectives on global patient supply\, cost of goods optimization\, and acc
 elerating clinical and commercial programs through digital innovation. Wi
 th strong end-to-end focus\, the agenda reflects the real challenges faci
 ng advanced therapy supply chains today.\n\nIf you are a supply chain lea
 der in cell and gene therapy\, this is your must-attend opportunity to co
 nnect with peers\, benchmark best practices\, and gain actionable insight
 s to build a resilient\, future-ready supply chain that delivers therapie
 s to patients\, reliably and at scale.\n\n&nbsp\;\n\nURLs:Tickets:&nbsp\;
 https://go.evvnt.com/3498265-2?pid=185&nbsp\;Brochure:&nbsp\;https://go.e
 vvnt.com/3498265-3?pid=185&nbsp\;\n\n&nbsp\;\n\nDate and Time: Tue\, 09 J
 un 2026 08:00 - Thu\, 11 Jun 2026 17:00\n\nVenue details: To be confirmed
 \, To be announced\, Washington\, District of Columbia\, United States\n\
 n&nbsp\;\n\nCategory: Conferences | Science\, Health &amp\; Medicine | Ph
 armaceuticals\n\n&nbsp\;\n\nPrices:Drug developer Pricing - 3 Day Pass: U
 SD 4397.00\,Drug Developer Pricing - Conference Only: USD 3099.00\,Academ
 ic Pricing - 3 Day Pass: USD 3797.00\,Academic Pricing - Conference Only:
  USD 2699.00\,Service Provider Pricing - 3 Day Pass: USD 5297.00\,Service
  Provider Pricing - Conference Only: USD 3799.00\n\n&nbsp\;\n\nSpeakers: 
 Albert Ribickas\, Manager\, Bloody and Marrow Transplant Laboratory\, Cli
 nical Trial and Commercial Product Handling Team\, Moffitt Cancer Center\
 , Robin White\, Deputy Technical Director\, ICCBBA\, Karen Moniz\, Direct
 or - Technical\, ICCBBA\, Luke Russell\, Executive Vice President\, Vyria
 d\, Sheri Winkels\, Senior Director of Quality and Compliance\, Vyriad\, 
 Tuo Wang\, Associate Director\, Supply Chain Category Management\, Sana B
 iotechnology\, Patrick Johnson\, Director - Supply Chain Patient Experien
 ce\, ProKidney\, Sherry Kallingal\, Senior Director - Operational Excelle
 nce\, ProKidney\, James Carr\, Director - US Supply Chain and Procurement
 \, Legend Biotech\, Rachel Rubiano\, Manager\, Clinical Operations and Lo
 gistics\, Kite Pharma Inc\, Afua Achampong-Duku\, Senior Manager\, Procur
 ement\, Immatics Gmbh\, Patrick Gailliot\, Senior Director - Patient Oper
 ations\, Abeona Therapeutics\, Gustavo Stanev Francisco\, Supply Chain Ma
 nager - Cell and Gene Therapy\, Roche\, Lizette Caballero\, Associate Dir
 ector - Clinical Cell Therapy Liaison\, Johnson and Johnson\, Marcos Pala
 cio\, Logistics Integrator Lead - Advanced Therapies\, Johnson and Johnso
 n\, Julia Batycky\, Cell and Gene Therapy\, Patient Operations Manager\, 
 Genentech\, Irena Maksimovic\, Senior Director - Strategy\, Business Oper
 ations and Clinical Supply Chain\, Bristol Myers Squibb\, Oscar Monroy\, 
 Senior Manager - Supply Chain Process Management\, Bristol Myers Squibb\,
  Arthur Wang\, Associate Director - Supply Chain Planning\, AstraZeneca\n
DTEND:20260611T170000
DTSTAMP:20260512T220028Z
DTSTART:20260609T080000
LOCATION:To be confirmed\, To be announced\, Washington\, District of Colu
 mbia\,
SEQUENCE:0
SUMMARY:In 2025\, cell and gene therapy reached a pivotal moment. Amid ris
 ing tariffs\, shifting regulations\, and capacity constraints\, the indus
 try gained c...
UID:4e2da9a1-46d9-426b-9f93-4963c6647f41
END:VEVENT
END:VCALENDAR